contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      viewerIsFollowing
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
      id
    }
    createdAt
    ... on Video {
      liveTime
      tags {
        viewerIsFollowing
        id
      }
    }
    ... on Webcast {
      liveTime
      tags {
        viewerIsFollowing
        id
      }
    }
    slug
    ... on CompanyReport {
      tags {
        viewerIsFollowing
        id
      }
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    pageUrl
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


magle-chemoswed-holding-ab-publ-releases-annual-report-for-2024

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

The Magle Group is founded on strategic acquisitions aimed at driving growth and diversifying risk. Today, the Group includes three operational areas. Magle Chemoswed, a contract development and manufacturing organization (CDMO). Magle PharmaCept, an established sales and marketing company for the development and direct sales of the Groups medical technology products, and Magle Biopolymers A/S, a specialized manufacturing organization of Dextran technology.

Magle Chemoswed Holding

Magle Chemoswed Holding's Annual Report for 2024 has been published on the Group’s website as of today.The annual report is available as a downloadable PDF document at www.maglegroup.com"In ...

<div class="mfn-preamble"><p><strong>Magle Chemoswed Holding's Annual Report for 2024 has been published on the Group’s website as of today.</strong></p></div><div class="mfn-body"><p>The annual report&nbsp;is available&nbsp;as a downloadable PDF document&nbsp;at <strong><a rel="noopener" href="https://eur02.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.maglegroup.com%2F&amp;data=05%7C02%7Caaron.wong%40maglegroup.com%7Ce2f949b575984fd25be608dd8bbb785e%7C949affc23c0d4f9893ff3a782ab199ea%7C0%7C0%7C638820359479861566%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=8tbuYQeyoKFd4S2trDLQ5PuflsfboqzYRFCNI5wuqH0%3D&amp;reserved=0">www.maglegroup.com</a></strong></p><p>"In 2024, we successfully integrated two important acquisitions into the group, Magle Biopharma and Magle Biopolymers. These two businesses, in combination with our existing operations, delivered solid revenue growth and improved the Groups profitability. This supports our ongoing commitment to delivering lasting value for our shareholders, partners, and the patients we serve," said Justin Pierce, Magle Group's CEO.</p><p>Aaron Wong, Magle Group's CFO, said, "This year’s financial results, with total revenue reaching SEK 256.2 million and a net profit of SEK 11.9 million, reflect sustained growth and underline the strength of our disciplined and strategic financial management".</p></div><div class="mfn-footer mfn-contacts mfn-c123be755a9c"><p><strong class="mfn-heading-1">Contacts Justin &amp; Aaron</strong></p><hr><p>Justin Pierce, CEO, phone +46 (0)70 593 58 21,&nbsp;<a rel="noopener" href="mailto:justin.pierce@maglechemoswed.com">justin.pierce@maglechemoswed.com</a></p><p>Aaron Wong, CFO, phone +46 (0)76 664 35 79, aaron.wong@maglegroup.com</p></div><div class="mfn-footer mfn-about mfn-70935ab259f1"><p><strong class="mfn-heading-1">About Us</strong></p><hr><p>The Magle Group aims to establish itself as a leader in high-quality life-changing healthcare innovations to meet medical needs through scientific excellence. The Magle Group is founded on strategic acquisitions aimed at driving growth and diversifying risk. Today, the Group includes three operational areas. Magle Chemoswed – a contract development and manufacturing organization (CDMO) with a strong reputation for its high-quality development and manufacturing expertise and Magle PharmaCept – an established sales and marketing company for development and direct sales of the Groups medical technology products. Magle Biopolymers A/S- a specialized manufacturing organization of Dextran technology. Learn more on&nbsp;<strong><a rel="noopener" href="http://www.maglechemoswed.com/">www.maglechemoswed.com</a></strong> and <strong><a rel="noopener" href="https://maglegroup.com/">www.maglegroup.com</a></strong><strong> </strong>and <strong><a rel="noopener" href="http://www.maglepharmacept.com">www.maglepharmacept.com</a></strong><strong> </strong>and <strong><a rel="noopener" href="https://maglebiopolymers.com/">www.maglebiopolymers.com</a></strong></p><p>Vator Securities is the Company's certified adviser on Nasdaq First North Growth Market and can be reached at <a rel="noopener" href="mailto:ca@vatorsec.se">ca@vatorsec.se</a> or +46 (0)8-580 065 99.</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/38caf37c-7b88-48a0-9bde-ff2bf7cccffc/magle-group-annual-report-2024-final.pdf" class="mfn-primary">Magle Group Annual Report 2024 Final</a></p></div>